Video

Peter LeWitt, MD

Publish date: July 17, 2015

At the 19th International Congress of Parkinson's Disease and Movement Disorders, Dr. LeWitt describes new levodopa preparations in development.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Oral device reduced obstructive sleep apnea, not sleepiness
MDedge Neurology
Does Dopamine Transporter Deficit Identify Prodromal Parkinson’s Disease in Patients With REM Sleep Behavior Disorder?
MDedge Neurology
Inhaled Levodopa Rapidly Improves Off States in Patients With Parkinson’s Disease
MDedge Neurology
Initiating Regular Exercise Is Associated With Slower Decline in Quality of Life in Parkinson’s Disease
MDedge Neurology
Novel Treatment for Rett Syndrome Shows Efficacy in Phase II Studies
MDedge Neurology
Alpha-Synuclein Is a Target of New Therapeutic Strategies for Parkinson’s Disease
MDedge Neurology
Earlier Treatment With Rotigotine May Have Long-Term Benefit for Patients With Parkinson’s Disease
MDedge Neurology
Does Low Muscle Strength Predict Parkinson’s Disease?
MDedge Neurology
Environmental and Behavioral Interventions May Alleviate Nonmotor Symptoms of Parkinson’s Disease
MDedge Neurology
John Duda, MD
MDedge Neurology

Related Articles